PHK
SRPT icon

Point72 Hong Kong’s Sarepta Therapeutics SRPT Stock Holding History

Point72 Hong Kong’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,657
Closed -$28.3K – 637
2025
Q2 		$28.3K Buy
+1,657
New +$70.7K ﹤0.01% 387
2024
Q3 		– Sell
-6,756
Closed -$1.07M – 628
2024
Q2 		$1.07M Buy
+6,756
New +$868K 0.06% 188
2024
Q1 		– Sell
-4,168
Closed -$402K – 778
2023
Q4 		$402K Buy
+4,168
New +$400K 0.02% 372
2022
Q4 		– Sell
-13,996
Closed -$1.55M – 1466
2022
Q3 		$1.55M Buy
13,996
+4,034
+40% +$407K 0.05% 428
2022
Q2 		$747K Buy
9,962
+3,808
+62% +$280K 0.03% 605
2022
Q1 		$481K Buy
6,154
+2,359
+62% +$181K 0.02% 713
2021
Q4 		$342K Sell
3,795
-3,708
-49% -$317K 0.01% 874
2021
Q3 		$694K Buy
+7,503
New +$578K 0.02% 848
2020
Q4 		– Sell
-17,696
Closed -$2.48M – 2029
2020
Q3 		$2.48M Buy
17,696
+15,094
+580% +$2.29M 0.26% 90
2020
Q2 		$417K Buy
+2,602
New +$354K 0.05% 376
2019
Q4 		– Sell
-2,363
Closed -$178K – 1439
2019
Q3 		$178K Buy
+2,363
New +$279K 0.05% 328
2019
Q1 		– Sell
-9
Closed -$1K – 1261
2018
Q4 		$1K Buy
+9
New +$1.13K ﹤0.01% 816
2017
Q3 		– Sell
-78
Closed -$3K – 1051
2017
Q2 		$3K Buy
+78
New +$2.54K ﹤0.01% 626

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Point72 Hong Kong's SRPT Position: Q3 2025 in Review

Point72 Hong Kong sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 1,657 shares — an estimated $28.3K sold.

Point72 Hong Kong first reported a position in SRPT in Q2 2017 and held it in 13 quarters. The position peaked at $2.48M in Q3 2020. 320 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.

  • Point72 Hong Kong reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 1,657 Sarepta Therapeutics shares in Q3 2025, an estimated $28.3K.
  • Point72 Hong Kong first reported a position in Sarepta Therapeutics in Q2 2017 and held it in 13 quarters.
  • Point72 Hong Kong's Sarepta Therapeutics position peaked at $2.48M in Q3 2020.
  • 320 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.